DNA — Ginkgo Bioworks Holdings Inc
In 2026 Q2, 4 of the 140 tracked hedge funds reported a position in Ginkgo Bioworks Holdings Inc (DNA), worth $7.58M combined. Over the quarter 4 opened or added, 0 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $5.35M | 0.00% | +437.4% |
| Caxton Associates | $1.53M | 0.03% | +124.8% |
| Quadrature | $456.73K | 0.00% | NEW |
| IMC | $240.92K | 0.00% | +18.6% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.